Literature DB >> 22002623

Pathways to the diagnosis of thyroid cancer in New South Wales: a population-based cross-sectional study.

Clare Kahn1, Leonardo Simonella, Mark Sywak, Steven Boyages, Owen Ung, Dianne O'Connell.   

Abstract

BACKGROUND: Over the past few decades, an increase in the incidence of thyroid cancer has been recorded in many countries around the world including Australia. Heightened medical surveillance and increased technological sensitivity could be contributing to greater detection of asymptomatic disease.
OBJECTIVES: To describe the pathways to diagnosis of thyroid cancer for a cohort of newly diagnosed patients in New South Wales (NSW), Australia, and compare these pathways by age, sex, place of residence, ethnic background, medical insurance status, and disease characteristics.
METHODS: A total of 452 newly diagnosed cases of thyroid cancer were recruited through the population-based NSW Central Cancer Registry. Participants completed a questionnaire and diary of doctor visits and investigations that led to their diagnosis. Tumor characteristics were obtained from pathology reports.
RESULTS: Forty percent of patients initially presented to their doctor with a lump or symptom specific to thyroid cancer and 60% had their cancer detected incidentally during a medical encounter. Men were more likely than women to be diagnosed after imaging for another health concern versus reporting a thyroid lump or symptom (p = 0.001). Thyroid cancer diagnosis after imaging for another health concern increased with age (p = 0.023), and larger tumors were less likely to be diagnosed after treatment for a benign thyroid disease (p = 0.040).
CONCLUSION: As the majority of participants had incidental diagnoses, the reported incidence of thyroid cancer is likely to be influenced by diagnostic technology and medical surveillance practices. This, however, probably only partly explains the observed rise in the incidence of thyroid cancer in NSW.

Entities:  

Mesh:

Year:  2011        PMID: 22002623     DOI: 10.1007/s10552-011-9852-2

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  8 in total

Review 1.  Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008.

Authors:  Nan Li; Xianglin L Du; Lorraine R Reitzel; Li Xu; Erich M Sturgis
Journal:  Thyroid       Date:  2013-01       Impact factor: 6.568

Review 2.  Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.

Authors:  Alvaro Sanabria; Luiz P Kowalski; Jatin P Shah; Iain J Nixon; Peter Angelos; Michelle D Williams; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2017-12-05       Impact factor: 3.147

3.  Factors Associated With Diagnosis and Treatment of Thyroid Microcarcinomas.

Authors:  Nazanene H Esfandiari; David T Hughes; David Reyes-Gastelum; Kevin C Ward; Ann S Hamilton; Megan R Haymart
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

4.  Trends in thyroid cancer incidence in Texas from 1995 to 2008 by socioeconomic status and race/ethnicity.

Authors:  Lorraine R Reitzel; Nga Nguyen; Nan Li; Li Xu; Seann D Regan; Erich M Sturgis
Journal:  Thyroid       Date:  2014-01-17       Impact factor: 6.568

5.  Identification of barriers and facilitators in nationwide implementation of standardized structured reporting in pathology: a mixed method study.

Authors:  J E M Swillens; C E Sluijter; L I H Overbeek; I D Nagtegaal; R P M G Hermens
Journal:  Virchows Arch       Date:  2019-07-03       Impact factor: 4.064

6.  Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials.

Authors:  Thomas J O'Grady; Cari M Kitahara; A Gregory DiRienzo; Francis P Boscoe; Margaret A Gates
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

7.  Identification of benign and malignant thyroid nodules by in vivo iodine concentration measurement using single-source dual energy CT: A retrospective diagnostic accuracy study.

Authors:  Shun-Yu Gao; Xiao-Yan Zhang; Wei Wei; Xiao-Ting Li; Yan-Ling Li; Min Xu; Ying-Shi Sun; Xiao-Peng Zhang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

8.  Secular Trends in the Epidemiologic Patterns of Thyroid Cancer in China Over Three Decades: An Updated Systematic Analysis of Global Burden of Disease Study 2019 Data.

Authors:  Yongze Li; Jianming Piao; Min Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-30       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.